Quint joins with CNBC and Trading Nation to discuss biotech stocks and their potential growth as China approves human trials for coronavirus treatments.
One of the best ways to learn more about Joule Financial is to join our free e-mail list. Periodically we will send out an e-mail newsletter for you to learn more about what we’re thinking or doing for client portfolios. We will never sell your information nor solicit you through this e-mail. It is for informational purposes only.